NewsStocksAngel One Reports Strong Client Growth, Tata Steel Record Production Among Key DevelopmentsAngel One Reports Strong Client Growth, Tata Steel Record Production Among Key Developments
Angel One demonstrated robust growth with December client funding book reaching ₹58.36 billion (up 43.3% YoY) and client base expanding to 35.71 million (up 21% YoY), while board meeting on January 15 will address stock split and interim dividend proposals. Other key developments include Tata Steel's record Q3 production of 6.34 million tons and IndiGo facing regulatory scrutiny over flight cancellations.
*this image is generated using AI for illustrative purposes only.
Markets concluded Wednesday's session on a subdued note, continuing the ongoing corrective phase as the Nifty moved closer to its first line of support at the 20-day DEMA. Analysts expect the index to find near-term support in the 26,000–26,100 zone, with stronger base around 25,800. Several major companies are drawing investor attention due to significant corporate developments and regulatory actions.
Angel One Delivers Strong Performance Metrics
Angel One reported robust business growth in December, demonstrating strong momentum across key operational parameters. The brokerage firm's latest performance metrics highlight significant expansion in both client base and funding operations:
| Performance Metric: | December | Year-on-Year Growth |
|---|---|---|
| Client Funding Book: | ₹58.36 billion | +43.30% |
| Total Client Base: | 35.71 million | +21.00% |
The company's board of directors will convene on January 15 to deliberate on a stock split proposal and declare the company's first interim dividend for financial year 2025-26. The meeting will also coincide with the announcement of December quarter earnings. Angel One has established January 21, 2026 as the record date for determining eligible shareholders, though the interim dividend payment remains subject to board approval.
Tata Steel Achieves Record Production
Tata Steel delivered exceptional operational performance in Q3, achieving its best-ever quarterly crude steel production milestone. The steel major's production metrics demonstrate strong operational efficiency:
| Performance Metric: | Q3 Achievement |
|---|---|
| Crude Steel Production: | 6.34 million tons |
| Year-on-Year Growth: | 12% |
| Sequential Growth: | 12% |
| Key Contributing Facilities: | Jamshedpur and Kalinganagar |
The production surge enabled Tata Steel India to cross the 6 million-ton delivery mark for the first time, representing the company's best-ever quarterly deliveries. The improvement was primarily driven by higher output at the Jamshedpur and Kalinganagar facilities.
Regulatory and Compliance Developments
The Competition Commission has initiated information gathering from IndiGo and aviation regulator DGCA to assess whether the country's largest airline engaged in unfair business practices. This regulatory review follows massive flight cancellations that occurred last month, prompting scrutiny of the airline's operational practices.
Eternal, the parent entity of Zomato and Blinkit, faces a goods and services tax demand totaling ₹3.69 crore. The demand order, which includes interest and penalty components, covers the period from April 2019 to March 2020 and was issued by the Additional Commissioner of State Tax (Appeals), West Bengal.
Corporate Restructuring and Product Launches
Shriram Finance has secured support from three proxy advisory firms for all proposals ahead of its extraordinary general meeting scheduled for January 14. The EGM will seek shareholder approval for a significant fund infusion arrangement:
| Transaction Details: | Specifications |
|---|---|
| Fund Infusion Amount: | ₹39,618 crore ($4.4 billion) |
| Investor: | MUFG Bank (Japan-based) |
| Stake Dilution: | 20% |
| Method: | Preferential issue shares |
United Breweries Limited, part of alcobev maker Heineken, expanded its product portfolio with the launch of Kingfisher Smooth, a strong beer targeting next-generation consumers. This launch strengthens the Kingfisher portfolio within India's mainstream strong beer segment.
Gland Pharma received approval from the United States Food and Drug Administration for its Abbreviated New Drug Application for Olopatadine Hydrochloride. The generic injectable and ophthalmic focused pharmaceutical company's product is therapeutically equivalent to the reference listed drug Pataday Once Daily Relief, 0.7%, manufactured by Alcon Laboratories Inc.
17
